ATA2152001A - Verwendung von selenhältigen präparaten - Google Patents

Verwendung von selenhältigen präparaten

Info

Publication number
ATA2152001A
ATA2152001A AT0021501A AT2152001A ATA2152001A AT A2152001 A ATA2152001 A AT A2152001A AT 0021501 A AT0021501 A AT 0021501A AT 2152001 A AT2152001 A AT 2152001A AT A2152001 A ATA2152001 A AT A2152001A
Authority
AT
Austria
Prior art keywords
selenious
preparations
selenious preparations
Prior art date
Application number
AT0021501A
Other languages
English (en)
Other versions
AT412448B (de
Original Assignee
Vis Vitalis Lizenz & Handels
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vis Vitalis Lizenz & Handels filed Critical Vis Vitalis Lizenz & Handels
Priority to AT0021501A priority Critical patent/AT412448B/de
Priority to US10/467,736 priority patent/US20040131702A1/en
Priority to CA002438164A priority patent/CA2438164A1/en
Priority to EP02710663A priority patent/EP1359923A1/de
Priority to JP2002571071A priority patent/JP2004518758A/ja
Priority to PCT/AT2002/000040 priority patent/WO2002072112A1/de
Priority to CNA028057643A priority patent/CN1529606A/zh
Publication of ATA2152001A publication Critical patent/ATA2152001A/de
Application granted granted Critical
Publication of AT412448B publication Critical patent/AT412448B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT0021501A 2001-02-13 2001-02-13 Verwendung von selenhältigen präparaten AT412448B (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AT0021501A AT412448B (de) 2001-02-13 2001-02-13 Verwendung von selenhältigen präparaten
US10/467,736 US20040131702A1 (en) 2001-02-13 2002-02-01 Use of selenite or preparation containing selenite for treating wounds
CA002438164A CA2438164A1 (en) 2001-02-13 2002-02-01 Use of preparations containing selenite or selenate
EP02710663A EP1359923A1 (de) 2001-02-13 2002-02-01 Verwendung von selenit- oder selenathaltigen präparaten zur behandlung von wunden
JP2002571071A JP2004518758A (ja) 2001-02-13 2002-02-01 亜セレン酸塩またはセレン酸塩を含有する製剤の使用
PCT/AT2002/000040 WO2002072112A1 (de) 2001-02-13 2002-02-01 Verwendung von selenit- oder selenathaltigen präparaten zur behandlung von wunden
CNA028057643A CN1529606A (zh) 2001-02-13 2002-02-01 用于治疗创伤的含有亚硒酸盐或硒酸盐的制剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0021501A AT412448B (de) 2001-02-13 2001-02-13 Verwendung von selenhältigen präparaten

Publications (2)

Publication Number Publication Date
ATA2152001A true ATA2152001A (de) 2004-08-15
AT412448B AT412448B (de) 2005-03-25

Family

ID=3669751

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0021501A AT412448B (de) 2001-02-13 2001-02-13 Verwendung von selenhältigen präparaten

Country Status (7)

Country Link
US (1) US20040131702A1 (de)
EP (1) EP1359923A1 (de)
JP (1) JP2004518758A (de)
CN (1) CN1529606A (de)
AT (1) AT412448B (de)
CA (1) CA2438164A1 (de)
WO (1) WO2002072112A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT412703B (de) 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
DE10321029A1 (de) * 2003-05-10 2004-12-02 Sigrid Heide Arzneimittel mit Selenit
WO2009043106A1 (en) * 2007-10-03 2009-04-09 Velacor Therapeutics Pty Ltd Inorganic selenium and angiogenesis
AT511159A1 (de) 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen
EP3616693A1 (de) * 2018-08-28 2020-03-04 Selo Medical GmbH Therapie von infektionen mit dem hochgefährlichen menschlichen papillomavirus

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1112164A (en) * 1977-08-02 1981-11-10 Joseph R. Levitt Therapeutic selenium compositions and the use thereof
US4512977A (en) * 1979-10-18 1985-04-23 Lundy Research Laboratories, Inc. Therapeutic selenium compositions and the use thereof
US4762726A (en) * 1983-12-30 1988-08-09 Kraft, Inc. Shelf stable acid food dressings containing fibrous protein complexes
US4668515A (en) * 1984-03-06 1987-05-26 Paul Bankit Method and compositions for sodium selenite administration
NZ228144A (en) * 1988-03-14 1991-03-26 Univ Bar Ilan Complexes of te and se, and methods of stimulating cells using them
DE3929411A1 (de) * 1988-09-22 1990-03-29 Siegfried Natterer Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung
DE69303813T2 (de) * 1992-03-11 1997-01-16 The Procter & Gamble Co., Cincinnati, Ohio Gekörnte grundsätze enthaltende psyllium-getränkezusammenstellungen
DE4320694C2 (de) * 1993-06-22 1999-11-11 Biosyn Arzneimittel Gmbh Vewendung von Selenverbindungen zur äußeren Anwendung bei Warzen
FR2725343B1 (fr) * 1994-10-10 1998-01-02 Jean Claude Attali Complexe insecticide et parasiticide, et procede de desinsectisation et de destruction des ectoparasites
US5747005A (en) * 1995-08-02 1998-05-05 Barels; Ronald R. Oil-based, anti-plaque dentifrice composition
CH690318A5 (fr) * 1995-09-06 2000-07-31 Mette Berger Composition d'additif nutritionnel pour administration intraveineuse.
US5648389A (en) * 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US6228347B1 (en) * 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
US6242010B1 (en) * 1999-07-21 2001-06-05 Thione International, Inc. Synergistic antioxidant compositions in management of hemorrhoids and other ano-rectal inflammatory conditions
AT412758B (de) * 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412703B (de) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung

Also Published As

Publication number Publication date
CA2438164A1 (en) 2002-09-19
WO2002072112A1 (de) 2002-09-19
AT412448B (de) 2005-03-25
US20040131702A1 (en) 2004-07-08
CN1529606A (zh) 2004-09-15
JP2004518758A (ja) 2004-06-24
EP1359923A1 (de) 2003-11-12

Similar Documents

Publication Publication Date Title
DE50212455D1 (de) Verwendung von Dimerdiolen
DE60211601D1 (de) Bereitstellung von positionsabhängigen Inhalten
DE60229061D1 (de) Herstellung und verwendung von nanopartikel
DE50115561D1 (de) Spektralphotometer und Verwendung desselben
DE60121953D1 (de) Herstellungsverfahren von arzneizubereitungen
DE60217126D1 (de) Herstellung von aminopyrimidinverbindungen
ATE533508T1 (de) Cripto-blockierende antikörper und ihre verwendung
DE60201859D1 (de) Pharmazeutische Verwendung von N-Carbamoylazol-Derivate
DE50012379D1 (de) Verwendung von nanoskaligen antischuppenwirkstoffen
ATE333794T1 (de) Verwendung herbizider mittel
DE60210864D1 (de) Modifiziertes fluoreszentes Protein
DE60126814D1 (de) Inhalation von stickoxid
DE50206094D1 (de) Substituierte isoindole und ihre verwendung
DE50103536D1 (de) Verwendung von kationischen Zubereitungen
DE50003755D1 (de) Satz von schmuckstücken
NO20041968L (no) Anvendelse av cystationin
ITMI20011532A0 (it) Cosmetico solido
DE50202730D1 (de) Substituierte isoindole und ihre verwendung
DE60233233D1 (de) Verminderung des haarwuchses
ATA2152001A (de) Verwendung von selenhältigen präparaten
DE50103099D1 (de) Verwendung von kationischen Zubereitungen
DE60007360D1 (de) Amorphe modifikation von torasemid
FR2819176B1 (fr) Composition cosmetique pelable
FR2830751B1 (fr) Composition cosmetique filmogene
EP1366056A4 (de) Zubereitung von deoxynukleoside

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee